Document is current
Any future updates will be listed below
-
Authors
Morán, Laura Ortega https://orcid.org/0000-0003-0456-7322
Mateo, Francisco José Pelegrín https://orcid.org/0000-0002-4340-9493
Balanyà, Rut Porta https://orcid.org/0000-0001-6179-9563
Revuelta, Jacobo Rogado https://orcid.org/0000-0002-9795-8762
Martínez, Silverio Ros
Fombella, José Pablo Berros https://orcid.org/0009-0004-1954-9703
Vázquez, Elena María Brozos https://orcid.org/0000-0003-4958-4142
Caro, Natalia Luque https://orcid.org/0009-0003-8676-6292
Langa, José Muñoz https://orcid.org/0000-0002-6942-8916
Fernández, Mercedes Salgado https://orcid.org/0000-0003-4134-1509
- License Information
-
More Information
Article History
Accepted: 10 July 2024
First Online: 7 August 2024
Declarations
:
: LOM: speaker at LEO Pharma, Rovi and Menarini. JRR: speaker at LEO Pharma. EMBV: member of the Advisory Board at Pfizer and Bayer; speaker at Rovi and LEO Pharma; travel and accommodation at Sanofi. NLC: speaker at Roche, AstraZeneca, Amgen and Merck. MSF: member of the Advisory Board at Pfizer; speaker at Sanofi, Rovi, LEO Pharma and Techdow. FJPM, RPB, SRM, JPBF and JML: nothing to disclose.
: Compliance with ethical standards. The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable.
